B
Benjaporn Buranrat
Researcher at Mahasarakham University
Publications - 31
Citations - 288
Benjaporn Buranrat is an academic researcher from Mahasarakham University. The author has contributed to research in topics: Apoptosis & Cell cycle. The author has an hindex of 7, co-authored 29 publications receiving 182 citations.
Papers
More filters
Journal ArticleDOI
Simvastatin potentiates doxorubicin activity against MCF-7 breast cancer cells.
TL;DR: Simvastatin acts synergistically with the anticancer drug doxorubicin against MCF-7 cells, possibly through a downregulation of the cell cycle or induction of apoptosis.
Journal ArticleDOI
Simvastatin and atorvastatin as inhibitors of proliferation and inducers of apoptosis in human cholangiocarcinoma cells
TL;DR: Investigation of whether statins induce human cholangiocarcinoma cell death and apoptosis and the mechanism by which statins act on cells found that cell death was probably induced via the mitochondrial pathway and statins could potentially be developed as novel chemotherapeutic agents for CCA.
Journal ArticleDOI
Cytoprotective effects of ferritin on doxorubicin-induced breast cancer cell death.
TL;DR: Ferritin plays a critical role in protecting MCF-7 cells against the chemotherapeutic drug doxorubicin and a targeted reduction of ferritin may be a useful strategy for overcoming chemoresistance in breast cancer.
Journal ArticleDOI
Cratoxy formosum leaf extract inhibits proliferation and migration of human breast cancer MCF-7 cells.
TL;DR: It is shown that CF leaf extract can inhibit cell proliferation, induce cell apoptosis, and reduce cell migration in the MCF-7 cell line, which could also be beneficial for enhancing the activity of anticancer drugs used to treat breast cancer.
Journal ArticleDOI
Effect of cold plasma and elicitors on bioactive contents, antioxidant activity and cytotoxicity of Thai rat-tailed radish microgreens.
Vijitra Luang-In,Worachot Saengha,Thipphiya Karirat,Benjaporn Buranrat,Khanit Matra,Sirirat Deeseenthum,Teeraporn Katisart +6 more
TL;DR: Cold plasma showed promise as an innovative tool to enhance bioactive compounds with chemopreventive benefits in microgreens.